Deciphera Pharmaceuticals Inc
NASDAQ:DCPH
Deciphera Pharmaceuticals Inc
Revenue
Deciphera Pharmaceuticals Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Deciphera Pharmaceuticals Inc
NASDAQ:DCPH
|
Revenue
$163.4m
|
CAGR 3-Years
57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Deciphera Pharmaceuticals Inc
Revenue Breakdown
Breakdown by Geography
Deciphera Pharmaceuticals Inc
Total Revenue:
163.4m
USD
|
United States:
121.5m
USD
|
Non-Us:
19.6m
USD
|
Germany:
18m
USD
|
Breakdown by Segments
Deciphera Pharmaceuticals Inc
Total Revenue:
163.4m
USD
|
Product Revenues, Net:
159.1m
USD
|
Collaboration Arrangement:
4.3m
USD
|
See Also
What is Deciphera Pharmaceuticals Inc's Revenue?
Revenue
163.4m
USD
Based on the financial report for Dec 31, 2023, Deciphera Pharmaceuticals Inc's Revenue amounts to 163.4m USD.
What is Deciphera Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 3Y
57%
Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Deciphera Pharmaceuticals Inc have been 57% over the past three years .